Kubota Ryuji, Furukawa Yoshitaka, Izumo Shuji, Usuku Koichiro, Osame Mitsuhiro
Third Department of Internal Medicine, Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, Japan.
Blood. 2003 Apr 15;101(8):3074-81. doi: 10.1182/blood-2002-08-2477. Epub 2002 Dec 12.
Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurologic disease caused by HTLV-1 infection, in which HTLV-1-infected CD4(+) T cells and HTLV-1-specific CD8(+) T cells may play a role in the disease pathogenesis. Patients with HAM/TSP have high proviral loads despite vigorous virus-specific CD8(+) T-cell responses; however, it is unknown whether the T cells are efficient in eliminating the virus in vivo. To define the dynamics of HTLV-1-specific CD8(+) T-cell responses, we investigated longitudinal alterations in HTLV-1 proviral load, amino acid changes in an immunodominant viral epitope, frequency of HTLV-1-specific T cells, and degeneracy of T-cell recognition in patients with HAM/TSP. We showed that the frequency and the degeneracy of the HTLV-1-specific CD8(+) T cells correlated well with proviral load in the longitudinal study. The proviral load was much higher in a patient with low degeneracy of HTLV-1-specific T cells compared to that in a patient with comparable frequency but higher degeneracy of the T cells. Furthermore, in a larger number of patients divided into 2 groups by the proviral load, those with high proviral load had lower degeneracy of T-cell recognition than those with low proviral load. Sequencing analysis revealed that epitope mutations were remarkably increased in a patient when the frequency and the degeneracy were at the lowest. These data suggest that HTLV-1-specific CD8(+) T cells with degenerate specificity are increased during viral replication and control the viral infection.
1型人类嗜T淋巴细胞病毒(HTLV-1)相关脊髓病/热带痉挛性截瘫(HAM/TSP)是一种由HTLV-1感染引起的炎性神经疾病,其中HTLV-1感染的CD4(+) T细胞和HTLV-1特异性CD8(+) T细胞可能在疾病发病机制中起作用。尽管有强烈的病毒特异性CD8(+) T细胞反应,但HAM/TSP患者的前病毒载量仍很高;然而,尚不清楚这些T细胞在体内清除病毒的效率如何。为了确定HTLV-1特异性CD8(+) T细胞反应的动态变化,我们研究了HAM/TSP患者中HTLV-1前病毒载量的纵向变化、免疫显性病毒表位的氨基酸变化、HTLV-1特异性T细胞的频率以及T细胞识别的简并性。我们发现在纵向研究中,HTLV-1特异性CD8(+) T细胞的频率和简并性与前病毒载量密切相关。与T细胞频率相当但简并性较高的患者相比,HTLV-1特异性T细胞简并性低的患者前病毒载量要高得多。此外,在按前病毒载量分为两组的大量患者中,前病毒载量高的患者T细胞识别的简并性低于前病毒载量低的患者。测序分析显示,当频率和简并性处于最低水平时,患者的表位突变显著增加。这些数据表明,具有简并特异性的HTLV-1特异性CD8(+) T细胞在病毒复制过程中增加,并控制病毒感染。